A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abataceptDivya Koura, Dimitrios Tzachanis, James Mirocha et al.|Blood Advances|2025Cited by 7
A Prospective Randomized Clinical Trial Comparing a Calcineurin-Free Gvhd Prophylaxis Regimen with Post-Transplant Cyclophosphamide and Abatacept to Methotrexate and TacrolimusDivya Koura, Dimitrios Tzachanis, James Mirocha et al.|Blood|2023Cited by 1
Comprehensive Molecular Profiling of Idiopathic Erythrocytosis By Genetic AncestryCaitlin O’Neill, Casey L. O’Connell, Ah‐Reum Jeong et al.|Blood|2019Cited by 0
Long-term follow-up of novel post-transplant cyclophosphamide (PTCy) and abatacept (aba) graft-versus-host disease (GVHD) prophylaxis regimen compared to tacrolimus and methotrexate.Kaitlyn C. Dykes, Dimitrios Tzachanis, Divya Koura et al.|Blood|2025Cited by 0
Exploring co-mutations in CML and ph(+) b-ALL with ABL1 variants: Correlations with survival and treatment response.Kaitlyn C. Dykes, Tiffany Tanaka, Nicholas J. Protopsaltis et al.|Blood|2025Cited by 0